RTF 2G

SECTION 2: Hazards identification

WHMIS 2015 Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet

Other hazards which do not result in classification

Warning: The product contains bovine material. All donor animals were sourced from BSE-free herds. The cattle received ante- and post mortem health inspection by a veterinarian, and they were apparently free from infectious and contagious material. However, the material should be treated as potentially infectious. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Not classified Classification according to Regulation OSHA 29 CFR 1910.1200 and Hazardous Product Regulation HPR (WHIMIS 2015) Not classified Adverse physicochemical, human health and environmental effects Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP], to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015) No labelling applicable Other labelling details :Up to 4,9% of the mixture consist of ingredients of unknown acute toxicity (dermal, inhalation) for human health and unknown hazard to the aquatic environment. 2.3. Other hazards Other hazards which do not result in classification :Warning: The product contains bovine material. All donor animals were sourced from BSE-free herds. The cattle received ante- and post mortem health inspection by a veterinarian, and they were apparently free from infectious and contagious material. However, the material should be treated as potentially infectious. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Comments :Composition: lyophilised powder containing inorganic and organic compounds and animal source material. Name Product identifier Conc. % Classification Classification according to w/w 29 CFR 1910.1200 (HCS) Regulation (EC) No. HPR (WHMIS 2015) 1272/2008 [CLP] Sodium Chloride CAS-No.: 7647-14-5 <1 Not classified EC-No.: 231-598-3 Sodium Azide CAS-No.: 26628-22-8 <0,2 Acute Toxicity – Oral, cat. 2 Acute Tox. 2 (Oral), H300 EC-No.: 247-852-1 Acute Toxicity – Dermal, cat. 2 (ATE=27 mg/kg bodyweight) EC Index-No.: 011-004-00-7 Acute Toxicity – Inhalation, cat. 2 Acute Tox. 2 (Dermal), H310 Specific Target Organ toxicity – (ATE=18 mg/kg bodyweight) Repeated exposure, cat. 2 Acute Tox. 2 (Inhalation), H330 Aquatic Acute cat. 1** (ATE=0.052 mg/l/4h) Aquatic Chronic cat. 1** STOT RE 2, H373 Aquatic Acute 1, H400 (M=1) Aquatic Chronic 1, H410 (M=1) EUH032 Comments :The mixture contains one substance listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA: Sodium azide. See Section 11 and 15. For exposure limits see Ch. 8, for hazard statements text see Ch. 16. * a range may be indicated, considering batch-to batch variation. **Environmental classification according to Reg. N. 1272/2008 (EC) and subsequent amendments. SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures after inhalation :If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice if adverse symptoms appear. First-aid measures after skin contact :Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild detergent and plenty of water until the removal of the mixture (15-20 minutes). Get medical advice if adverse symptoms appear.